Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler study
Headache: The Journal of Head and Face Pain · 2025
DOI: 10.1111/head.14999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2025. Verfasst von Soohyun Cho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea. Hauptthemen laut MEDLINE: Nimodipine, Vasospasm, Intracranial, Vasodilator Agents, Vasoconstriction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Samjin Pharmaceutical Co, National Research Foundation of Korea.
Abstract (Originalsprache)
Objectives/Background Although nimodipine is commonly used to treat reversible cerebral vasoconstriction syndrome (RCVS), its disease‐modifying effects are not yet understood. We prospectively investigated the effect of nimodipine and treatment initiation timing on the prevention of worsened vasoconstriction in patients with angiogram‐proven RCVS.
Methods
In this prospective cohort study, we recruited patients with angiogram‐proven RCVS who visited a single headache clinic between June 2019 and November 2021. To evaluate the mean flow velocities (MFVs) of the middle cerebral arteries, patients underwent transcranial Doppler at baseline and were then serially followed up after 10, 20, 30, and 90 days. Oral nimodipine treatment was initiated after the baseline transcranial Doppler study. We estimated the worsening of vasoconstriction using the area of total time spent with MFVs above the baseline value (“MFV area”).
Results
A total of 32 patients (51.5 ± 10.3 years old, 91% female) completed this study. During nimodipine treatment, MFVs gradually decreased in 94% ( n = 30/32) of patients ( p < 0.001). The MFVs in the early treatment group (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea.
- Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Soohyun Cho, Mi Ji Lee
Förderung
- Samjin Pharmaceutical Co
- National Research Foundation of Korea
Zitieren
APA
Cho, S., Seong, M., & Lee, M. J. (2025). Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler study. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14999
Vancouver
Cho S, Seong M, Lee MJ. Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler study. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.14999
BibTeX
@article{Cho2025,
author = {Cho, Soohyun and Seong, Minjung and Lee, Mi Ji},
title = {Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler study},
journal = {Headache: The Journal of Head and Face Pain},
year = {2025},
doi = {10.1111/head.14999}
}
EUVIMED